Skip to content

An evaluation of a new approach to reduce antimicrobial prescribing in care home residents

An evaluation of a multifaceted intervention to reduce antimicrobial prescribing in care home residents [REducing Antimicrobials in Care Homes (REACH)]: a non-randomised feasibility study and process evaluation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10441831
Enrollment
50
Registered
2016-04-25
Start date
2016-05-01
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections in care home residents and antimicrobial prescribing Infections and Infestations

Interventions

A feasibility study will be conducted in six care homes for older people (three care homes in Northern Ireland and three care homes in the Warwick/Coventry area). At this stage, the exact content of

Sponsors

Queen's University Belfast (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Care homes: 1. Care homes (some with/without nursing care), principally providing 24 hour care for older residents 2. A minimum of 20 (permanent) residents 3. Associated with a small number of general practices (up to four per home providing care for a minimum of 80% of residents within a home) 4. An exclusive arrangement with one pharmacy for dispensing medications Care home staff: 1. Working in the participating care homes 2. Willing to participate in focus group discussions General Practitioners: 1. Working with the participating care homes 2. Willing to participate in interviews

Exclusion criteria

Exclusion criteria: 1. Not meeting the inclusion criteria 2. Not providing written informed consent

Design outcomes

Primary

MeasureTime frame
Because this is a feasibility study, we are unable to judge effectiveness. The outcomes that we are interested in for this feasibility study are predominantly process-related and outlined as follows: 1. Acceptability of the intervention in terms of recruitment and delivery of training as assessed by collecting data on recruitment of care homes (3 months from the start of the project, based on the number of homes approached and the number recruited) and attendance at training events (after the training events have taken place during months 9-12) 2. The feasibility of measuring appropriateness of prescribing and collecting dispensing data from community pharmacies (12 months pre-baseline and 6 months from baseline) 3. Comprehensive overview of the implementation of the intervention as measured through process evaluation (observation, interviews and focus groups) over the course of the study (over 6 months).

Secondary

MeasureTime frame
There will be two main secondary outcomes for this feasibility study: 1. The costs of implementing the intervention which will be recording resource used associated with labour, training, intervention materials, equipment and space. These data will be collected over the course of the study through the use of documentation that will be prepared for the study. 2. The likelihood of being able to recruit to a larger definitive study will be assessed by distributing a short questionnaire (providing details about a proposed definitive study) to care homes in selected geographic areas (month 21)

Countries

England, Northern Ireland, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026